Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
51.54
1.40 (2.79%)
At close: Aug 15, 2025, 11:49 AM

Anbio Biotechnology Class A Ordinary Shares Revenue

Anbio Biotechnology Class A Ordinary Shares reported an annual revenue of $8.19M, reflecting a 21.95% growth. For the quarter ending December 31, 2024, Anbio Biotechnology Class A Ordinary Shares generated $2.53M in revenue.
Revenue (ttm)
8.19M
Revenue Growth
21.95%
Price / Sales Ratio
29.81
Revenue / Employee
303.15K
Employees
27
Market Cap
2.26B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.